Related content

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

By Ou Xueling   Cai Shaohui   Liu Peng   Zeng Jun   He Yuwen   Wu Xinyao   Du Jun  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 525-533

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression

By Wobser Marion   Voigt Heike   Houben Roland   Eggert Andreas   Freiwald Matthias   Kaemmerer Ulrike   Kaempgen Eckhart   Schrama David   Becker Juergen  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1017-1024

Springer Publishing Company

Access to resources Recommend Favorite

Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy

By                      

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 929-934

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation

By                        

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1574-1578

Spandidos Publications

Access to resources Recommend Favorite

(-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells

By                      

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 546-550

Spandidos Publications

Access to resources Recommend Favorite